DocDollars

Trisalus Life Sciences, Inc.

CO · United States · Reporting entity ID 100000000140

Total reported 2019–2025
$14.4M
#401 of 2,960 reporting companies — 0% of all reported industry payments
$4.85M in general payments across 10,196 records, plus $9.53M in research funding across 507 records.

How it breaks down

General payments $4,850,140
Research funding $9,528,909

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Trisalus Life Sciences, Inc. reported $14.4M to US doctors and teaching hospitals from 2019 to 2025, ranking #401 of 2,960 reporting companies. 66% of that was research funding and 34% general payments such as consulting, speaking, food and travel. 10,196 general payment records and 507 research records were filed.

Common questions about Trisalus Life Sciences, Inc.

How much has Trisalus Life Sciences, Inc. paid US doctors?

Trisalus Life Sciences, Inc. reported $14,379,049 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $4,850,140 in general payments, $9,528,909 in research funding.

How does Trisalus Life Sciences, Inc. rank among drug and device companies?

It ranks #401 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Trisalus Life Sciences, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.